Lipocine Inc
Biotechnology
Healthcare
LPCN
5.35 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.83
52 week high
6.09
high
2.86
52 week low
0.00
low
2.75
growth
-42.98 %
previous Close
2.86
P/E ratio
market cap
16.48 M
div yield
0
usd
Jun 2025
qoq
revenue
623 K
563.57 %
net incoming
-2.21 M
-18.28 %
eps
0.00 %
-17.14 %
eps surprise
-2.50 %
net profit margin
-354.13 %
1632.00 %
operating incoming
0.00 %
net change in cash
2.69 M
194.32 %
cash on hand
6.04 M
80.17 %
cost of revenue
0.00 %
top top